Osterweis Capital Management Inc Replimune Group, Inc. Transaction History

Osterweis Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $1.06 Million - $1.48 Million	-66,605 Reduced 56.51%	51,250 $876,000
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $516,606 - $795,541	-33,010 Reduced 21.88%	117,855 $2.74 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $643,875 - $1.07 Million	36,835 Added 32.3%	150,865 $2.66 Million
Q4 2022 Feb 14, 2023	SELL	$17.09 - $27.91 $175,770 - $287,054	-10,285 Reduced 8.27%	114,030 $3.1 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $225,342 - $305,511	-14,445 Reduced 10.41%	124,315 $2.15 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $527,671 - $791,507	39,615 Added 39.96%	138,760 $2.43 Million
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $786,612 - $1.54 Million	-51,615 Reduced 34.24%	99,145 $1.68 Million
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $749,803 - $1.01 Million	29,485 Added 24.31%	150,760 $4.09 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $707,981 - $965,962	-24,430 Reduced 16.77%	121,275 $3.6 Million
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $1.06 Million - $1.47 Million	-37,225 Reduced 20.35%	145,705 $5.6 Million
Q1 2021 May 14, 2021	BUY	$30.22 - $45.57 $3.25 Million - $4.91 Million	107,705 Added 143.18%	182,930 $5.58 Million
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $1.77 Million - $3.96 Million	75,225 New	75,225 $2.87 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.